Charles Michaud's most recent trade in Q32 Bio Inc. was a trade of 1,708 Common Stock done at an average price of $0.6 . Disclosure was reported to the exchange on Jan. 3, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Q32 Bio Inc.
|
Michaud Charles | See Remarks | Sale of securities on an exchange or to another person at price $ 0.57 per share. | 03 Jan 2024 | 1,708 | 11,598 (0%) | 0% | 0.6 | 975 | Common Stock |
Q32 Bio Inc.
|
Charles Michaud | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2024 | 2,640 | 13,306 (0%) | 0% | - | Common Stock | |
Q32 Bio Inc.
|
Michaud Charles | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2024 | 2,640 | 5,360 | - | - | Restricted Stock Units | |
Q32 Bio Inc.
|
Charles Michaud | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2024 | 1,056 | 1,088 | - | - | Restricted Stock Units | |
Q32 Bio Inc.
|
Charles Michaud | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2024 | 1,056 | 10,666 (0%) | 0% | - | Common Stock | |
Q32 Bio Inc.
|
Charles Michaud | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2024 | 544 | 9,610 (0%) | 0% | - | Common Stock | |
Q32 Bio Inc.
|
Charles Michaud | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2024 | 544 | 0 | - | - | Restricted Stock Units |